Bristol-Myers To Nearly Double Japan Sales Staff By 2012
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb says it plans to nearly double its staff of sales representatives in Japan or more by 2012. The company, which now has about 460 medical representatives in Japan, plans to add another 300 to reach 760, primarily to market its cancer drugs expected to be available as early as 2011. The company said the added staff also would focus on marketing thrombosis and hepatitis C drugs during that period. Other products are expected to come on line in Japan by 2016. (Click here for more - a subscription may be required)